This paper is in the following e-collection/theme issue:

Pharmacovigilance (129) JMIR Theme Issue: COVID-19 Special Issue (2394) Infectious Diseases (non-STD/STI) (1490) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (147) Pharmacology and Pharmaceutics (52) COVID-19 Vaccination (128) Vaccination and Immunization in the Digital Age (347)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45263, first published .
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Authors of this article:

Hung Thai-Van1, 2, 3 Author Orcid Image ;   Marie-Blanche Valnet-Rabier4 Author Orcid Image ;   Maëva Anciaux2 Author Orcid Image ;   Aude Lambert5 Author Orcid Image ;   Anaïs Maurier6 Author Orcid Image ;   Judith Cottin7 Author Orcid Image ;   Tessa Pietri8 Author Orcid Image ;   Alexandre Destère9 Author Orcid Image ;   Marlène Damin-Pernik10 Author Orcid Image ;   Fanny Perrouin11 Author Orcid Image ;   Haleh Bagheri12 Author Orcid Image
Article Authors Cited by (4) Tweetations (894) Metrics

Journals

  1. Reynard P, Thai-Van H. Drug-induced hearing loss: Listening to the latest advances. Therapies 2024;79(2):283 View
  2. Liew X, Tang Z, Ong Y, See K. Hearing Loss after COVID-19 and Non-COVID-19 Vaccination: A Systematic Review. Vaccines 2023;11(12):1834 View
  3. Thai-Van H, Bagheri H, Valnet-Rabier M. Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment. Vaccines 2024;12(2):181 View
  4. . Elasomeran/tozinameran. Reactions Weekly 2024;2000(1):153 View